Prevalence and treatment outcomes of hydrocephalus among children with craniofacial syndromes

Saga Jönsson; Daniel Nilsson; Peter Tarnow; Giovanni Maltese; Madiha Bhatti-Søfteland; Lars Kölby; Tobias  Hallén

doi:10.2340/jphs.v60.42957

Authors

Saga Jönsson Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Daniel Nilsson Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden
Peter Tarnow Department of Plastic Surgery, University of Gothenburg, The Sahlgrenska Academy, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden
Giovanni Maltese Department of Plastic Surgery, University of Gothenburg, The Sahlgrenska Academy, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden
Madiha Bhatti-Søfteland Department of Plastic Surgery, University of Gothenburg, The Sahlgrenska Academy, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden
Lars Kölby Department of Plastic Surgery, University of Gothenburg, The Sahlgrenska Academy, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden
Tobias Hallén Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden https://orcid.org/0000-0002-3628-7686

DOI:

https://doi.org/10.2340/jphs.v60.42957

Keywords:

Hydrocephalus, craniofacial syndromes, ventriculoperitoneal shunt, shunt revision

Abstract

Introduction: Hydrocephalus is more common in patients with craniofacial syndromes (CS) relative to non-syndromic craniosynostosis, and the optimal management is challenging. This study examined the prevalence and treatment outcomes of hydrocephalus among children with CS.

Materials and methods: We performed a retrospective review of medical records for all children with established CS and registered in the Gothenburg Craniofacial Registry between 1975 and 2022. This review included analyses of data regarding patient demographics, radiological imaging, hydrocephalus treatment modalities, and shunt revisions.

Results: Eligible patients (n = 193) included those with CS, including Pfeiffer (n = 13), Crouzon (n = 57), Apert (n = 49), Muenke (n = 25), and Saethre–Chotzen (n = 49) syndromes. A total of 22 patients (11.4%) presented hydrocephalus requiring treatment [Pfeiffer, n = 8 (61.5%); Crouzon, n = 13 (22.8%); and Apert, n = 1 (2.0%)]. Nineteen (9.8%) patients underwent ventricular shunt insertion, and three (1.6%) underwent endoscopic third ventriculostomy as a first procedure. None of the Muenke or Saethre–Chotzen patients required hydrocephalus treatment. Seventeen (85%) patients with shunts required revision mainly due to shunt obstruction. Pfeiffer patients had the highest risk of both developing hydrocephalus requiring treatment and needing shunt revision (p < 0.001 and p = 0.004, respectively). Approximately 40% of patients with Pfeiffer, Crouzon, or Apert presented ventriculomegaly not requiring treatment.

Conclusions: Hydrocephalus requiring treatment is common in Pfeiffer and Crouzon patients but rare in Apert, Muenke, or Saethre–Chotzen syndrome. Shunt treatment is often associated with complications that require revisions, emphasizing the importance of distinguishing non-progressive ventriculomegaly from hydrocephalus requiring treatment.

Downloads

Download data is not yet available.

References

Cinalli G, Sainte-Rose C, Kollar EM, et al. Hydrocephalus and craniosynostosis. J Neurosurg. 1998;88(2):209–214. https://doi.org/10.3171/jns.1998.88.2.0209 DOI: https://doi.org/10.3171/jns.1998.88.2.0209

Di Rocco F, Jucá CE, Arnaud E, et al. The role of endoscopic third ventriculostomy in the treatment of hydrocephalus associated with faciocraniosynostosis. J Neurosurg Pediatr. 2010;6(1):17–22. https://doi.org/10.3171/2010.3.PEDS09484 DOI: https://doi.org/10.3171/2010.3.PEDS09484

Frassanito P, Palombi D, Tamburrini G. Craniosynostosis and hydrocephalus: relevance and treatment modalities. Childs Nerv Syst. 2021;37(11):3465–3473. https://doi.org/10.1007/s00381-021-05158-z DOI: https://doi.org/10.1007/s00381-021-05158-z

Collmann H, Sörensen N, Krauss J. Hydrocephalus in craniosynostosis: a review. Childs Nerv Syst. 2005;21(10):902–912. https://doi.org/10.1007/s00381-004-1116-y DOI: https://doi.org/10.1007/s00381-004-1116-y

Tamburrini G, Caldarelli M, Massimi L, et al. Intracranial pressure monitoring in children with single suture and complex craniosynostosis: a review. Childs Nerv Syst. 2005;21(10):913–921. https://doi.org/10.1007/s00381-004-1117-x DOI: https://doi.org/10.1007/s00381-004-1117-x

Coll G, El Ouadih Y, Abed Rabbo F, et al. Hydrocephalus and Chiari malformation pathophysiology in FGFR2-related faciocraniosynostosis: a review. Neurochirurgie. 2019;65(5):264–268. DOI: https://doi.org/10.1016/j.neuchi.2019.09.001

Azzolini A, Magoon K, Yang R, et al. Ventricular shunt complications in patients undergoing posterior vault distraction osteogenesis. Childs Nerv Syst. 2020;36(5):1009–1016. https://doi.org/10.1007/s00381-019-04403-w DOI: https://doi.org/10.1007/s00381-019-04403-w

Tamburrini G, Caldarelli M, Massimi L, et al. Complex craniosynostoses: a review of the prominent clinical features and the related management strategies. Childs Nerv Syst. 2012;28(9):1511–1523. DOI: https://doi.org/10.1007/s00381-012-1819-4

Tarnow P, Kölby L, Maltese G, et al. Incidence of non-syndromic and syndromic craniosynostosis in Sweden. J Craniofac Surg. 2022;33(5):1517–1520. https://doi.org/10.1097/SCS.0000000000008457 DOI: https://doi.org/10.1097/SCS.0000000000008457

Noetzel MJ, Marsh JL, Palkes H, et al. Hydrocephalus and mental retardation in craniosynostosis. J Pediatr. 1985;107(6):885–892. https://doi.org/10.1016/S0022-3476(85)80181-5 DOI: https://doi.org/10.1016/S0022-3476(85)80181-5

Moore MH, Hanieh A. Hydrocephalus in pfeiffer syndrome. J Clin Neurosci. 1994;1(3):202–204. https://doi.org/10.1016/0967-5868(94)90030-2 DOI: https://doi.org/10.1016/0967-5868(94)90030-2

Proudman TW, Clark BE, Moore MH, et al. Central nervous system imaging in Crouzon’s syndrome. J Craniofac Surg. 1995;6(5):401–405. https://doi.org/10.1097/00001665-199509000-00016 DOI: https://doi.org/10.1097/00001665-199509000-00016

den Ottelander BK, de Goederen R, van Veelen MC, et al. Muenke syndrome: long-term outcome of a syndrome-specific treatment protocol. J Neurosurg Pediatr. 2019;24(4):415–422. https://doi.org/10.3171/2019.5.PEDS1969 DOI: https://doi.org/10.3171/2019.5.PEDS1969

den Ottelander BK, van Veelen MC, de Goederen R, et al. Saethre–Chotzen syndrome: long-term outcome of a syndrome-specific management protocol. Dev Med Child Neurol. 2021;63(1):104–110. https://doi.org/10.1111/dmcn.14670 DOI: https://doi.org/10.1111/dmcn.14670

Munarriz PM, Pascual B, Castaño-Leon AM, et al. Apert syndrome: cranial procedures and brain malformations in a series of patients. Surg Neurol Int. 2020;11:361. https://doi.org/10.25259/SNI_413_2020 DOI: https://doi.org/10.25259/SNI_413_2020

Fearon JA, Podner C. Apert syndrome: evaluation of a treatment algorithm. Plast Reconstr Surg. 2013;131(1):132–142. DOI: https://doi.org/10.1097/PRS.0b013e3182729f42

Coll G, Arnaud E, Collet C, et al. Skull base morphology in fibroblast growth factor receptor type 2-related faciocraniosynostosis: a descriptive analysis. Neurosurgery. 2015;76(5):571–583. DOI: https://doi.org/10.1227/NEU.0000000000000676

Tcherbbis Testa V, Jaimovich S, Argañaraz R, et al. Management of ventriculomegaly in pediatric patients with syndromic craniosynostosis: a single center experience. Acta Neurochir (Wien). 2021;163(11):3083–3091. https://doi.org/10.1007/s00701-021-04980-3 DOI: https://doi.org/10.1007/s00701-021-04980-3

Breik O, Mahindu A, Moore MH, et al. Apert syndrome: surgical outcomes and perspectives. J Craniomaxillofac Surg. 2016;44(9):

1238–1245. https://doi.org/10.1016/j.jcms.2016.06.001 DOI: https://doi.org/10.1016/j.jcms.2016.06.001

Cinalli G, Renier D, Sebag G, et al. Chronic tonsillar herniation in Crouzon’s and Apert’s syndromes: the role of premature synostosis of the lambdoid suture. J Neurosurg. 1995;83(4):575–582. https://doi.org/10.3171/jns.1995.83.4.0575 DOI: https://doi.org/10.3171/jns.1995.83.4.0575

Di Rocco C, Massimi L, Tamburrini G. Shunts versus endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review. Childs Nerv Syst. 2006;22(12):1573–1589. https://doi.org/10.1007/s00381-006-0194-4 DOI: https://doi.org/10.1007/s00381-006-0194-4

Stone JJ, Walker CT, Jacobson M, et al. Revision rate of pediatric ventriculoperitoneal shunts after 15 years. J Neurosurg Pediatr. 2013;11(1):15–19. DOI: https://doi.org/10.3171/2012.9.PEDS1298

Drake JM, Kestle JR, Tuli S. CSF shunts 50 years on: past, present and future. Childs Nerv Syst. 2000;16(10-11):800–804. https://doi.org/10.1007/s003810000351 DOI: https://doi.org/10.1007/s003810000351

Di Rocco C, Marchese E, Velardi F. A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991–1992 Education Committee of the ISPN. Childs Nerv Syst. 1994;10(5):321–327. https://doi.org/10.1007/BF00335171 DOI: https://doi.org/10.1007/BF00335171

Anderson IA, Saukila LF, Robins JMW, et al. Factors associated with 30-day ventriculoperitoneal shunt failure in pediatric and adult patients. J Neurosurg. 2018;130(1):145–153. https://doi.org/10.3171/2017.8.JNS17399 DOI: https://doi.org/10.3171/2017.8.JNS17399

Khan F, Shamim MS, Rehman A, et al. Analysis of factors affecting ventriculoperitoneal shunt survival in pediatric patients. Childs Nerv Syst. 2013;29(5):791–802. https://doi.org/10.1007/s00381-012-2004-5 DOI: https://doi.org/10.1007/s00381-012-2004-5

Bonfield CM, Shannon CN, Reeder RW, et al. Hydrocephalus treatment in patients with craniosynostosis: an analysis from the Hydrocephalus Clinical Research Network prospective registry. Neurosurg Focus. 2021;50(4):E11. https://doi.org/10.3171/2021.1.FOCUS20979 DOI: https://doi.org/10.3171/2021.1.FOCUS20979

Massimi L, Pennisi G, Frassanito P, et al. Chiari type I and hydrocephalus. Childs Nerv Syst. 2019;35(10):1701–1709. https://doi.org/10.1007/s00381-019-04245-6 DOI: https://doi.org/10.1007/s00381-019-04245-6